中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
25期
177-178
,共2页
董洪武%王明生%赵霞%李明昌%王河%任海明%王磊
董洪武%王明生%趙霞%李明昌%王河%任海明%王磊
동홍무%왕명생%조하%리명창%왕하%임해명%왕뢰
老年冠心病%阿司匹林%氯吡格雷
老年冠心病%阿司匹林%氯吡格雷
노년관심병%아사필림%록필격뢰
Elderly coronary heart disease%Aspirin%Clopidogrel
目的:分析比较阿司匹林与氯吡格雷治疗老年冠心病的临床疗效。方法选择老年冠心病患者96例作为研究对象,按治疗方法的不同,分为对照组(n=48例)和观察组(n=48例),对照组给予单纯阿司匹林治疗,观察组给予氯吡格雷治疗,对两组患者的临床效果进行分析比较。结果两组患者治疗前的 PAG、PT、APTT 指标比较差异不显著(P>0.05);观察组治疗后的 PAG、PT、APTT 指标分别为(31.26±5.23)%、(14.38±2.67)s、(40.23±2.34)s,优于对照组与的(43.78±8.43)%、(12.87±1.89)s、(48.51±1.67)s,差异有统计学意义(P <0.05);观察组胃黏膜出血率为4.17%,对照组胃黏膜出血率为12.50%,差异有统计学意义(P <0.05)。结论老年冠心病采取氯吡格雷治疗的临床效果显著,且安全性好。
目的:分析比較阿司匹林與氯吡格雷治療老年冠心病的臨床療效。方法選擇老年冠心病患者96例作為研究對象,按治療方法的不同,分為對照組(n=48例)和觀察組(n=48例),對照組給予單純阿司匹林治療,觀察組給予氯吡格雷治療,對兩組患者的臨床效果進行分析比較。結果兩組患者治療前的 PAG、PT、APTT 指標比較差異不顯著(P>0.05);觀察組治療後的 PAG、PT、APTT 指標分彆為(31.26±5.23)%、(14.38±2.67)s、(40.23±2.34)s,優于對照組與的(43.78±8.43)%、(12.87±1.89)s、(48.51±1.67)s,差異有統計學意義(P <0.05);觀察組胃黏膜齣血率為4.17%,對照組胃黏膜齣血率為12.50%,差異有統計學意義(P <0.05)。結論老年冠心病採取氯吡格雷治療的臨床效果顯著,且安全性好。
목적:분석비교아사필림여록필격뢰치료노년관심병적림상료효。방법선택노년관심병환자96례작위연구대상,안치료방법적불동,분위대조조(n=48례)화관찰조(n=48례),대조조급여단순아사필림치료,관찰조급여록필격뢰치료,대량조환자적림상효과진행분석비교。결과량조환자치료전적 PAG、PT、APTT 지표비교차이불현저(P>0.05);관찰조치료후적 PAG、PT、APTT 지표분별위(31.26±5.23)%、(14.38±2.67)s、(40.23±2.34)s,우우대조조여적(43.78±8.43)%、(12.87±1.89)s、(48.51±1.67)s,차이유통계학의의(P <0.05);관찰조위점막출혈솔위4.17%,대조조위점막출혈솔위12.50%,차이유통계학의의(P <0.05)。결론노년관심병채취록필격뢰치료적림상효과현저,차안전성호。
Objective To analyze the clinical effect of aspirin and clopidogrel in the treatment of coronary heart disease. Methods 96 elderly patients with coronary heart disease (CHD) were divided into control group (n=48) and observation group (n=48 cases). The control group was treated with aspirin, and the clinical effect of the two groups was analyzed and compared. Results Two groups of patients before treatment, PT, APTT, PAG index were not significantly different (P>0.05), PAG, APTT, PT index were (31.26±5.23) %, (14.38±2.67) s, (40.23±2.34) s, better than the control group (43.78±8.43)%, (8.43±12.87) s, (1.89±1.67) s, the difference was statistically significant (P<0.05), the control group was 12.50%, the difference was statistically significant (P<0.05). Conclusion Elderly patients with coronary heart disease treated with clopidogrel, the clinical effect is significant, and the safety is good.